# Zydus Lifesciences Limited clinical trials: 21 (2026)

Updated November 19, 2026.

ClinicalTrials.gov lists 21 trials with Zydus Lifesciences Limited as lead sponsor, 1 of them recruiting or not yet recruiting, as read on November 19, 2026.

## The full list

Clinical trials led by Zydus Lifesciences Limited: 21 rows for $5, every trial on ClinicalTrials.gov as read on November 19, 2026. Columns: NCT ID, Title, Sponsor, Sponsor class, Phase, Status, Conditions, Condition groups (MeSH), Interventions, Start date, First posted, Last update posted, Enrollment, Location countries, Read on, Source. Pay by card with no account. Prices exclude VAT. CSV and Excel files with the columns this page does not show (sponsor class, condition groups (MeSH), interventions, start date, last update posted and location countries), which open on your screen as soon as the payment clears and come by email.

Buy: https://specstream.ai/data/clinical-trials/company/zydus-lifesciences-limited

SpecStream is the live web data engine for teams and agents. It reads ClinicalTrials.gov each morning, and this page is that reading. Ask for the sponsors, conditions, phases or places you follow and each new or changed trial arrives in your sheet, CRM, Slack or agent with the sponsor, phase, status and sites.

- Trials: 21
- Recruiting or not yet: 1
- Read on: November 19, 2026

## Trials

The 21 newest of 21, each linked to its ClinicalTrials.gov record. The full list holds every one.

| First posted | NCT ID | Title | Sponsor | Phase | Status | Conditions | Enrollment | Source |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| May 3, 2024 | NCT06398808 | A Study to Evaluate the Efficacy and Safety of ZYIL1 Oral Capsules for the Treatment of Patients With Mild to Moderately Active Ulcerative... | Zydus Lifesciences Limited | Phase 2 | Completed | Ulcerative Colitis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT06398808) |
| August 8, 2023 | NCT05981040 | Efficacy, Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ZYIL1 in Patients With Amyotrophic Lateral Sclerosis | Zydus Lifesciences Limited | Phase 2 | Completed | Amyotrophic Lateral Sclerosis | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05981040) |
| June 22, 2023 | NCT05911828 | A Study to Determine Safety, Tolerability, and Pharmacokinetics of Different Orally Administered Regimens of the Combination... | Zydus Lifesciences Limited | Phase 1 | Unknown | Uncomplicated Malaria, Asymptomatic Condition, Falciparum Malaria | 36 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05911828) |
| May 24, 2023 | NCT05872269 | A Study to Evaluate the Safety and Effectiveness of Saroglitazar 4 mg in Patients With NAFLD With Comorbidities | Zydus Lifesciences Limited | Phase 4 | Unknown | NAFLD, Obesity, Type 2 Diabetes, Dyslipidemias, Metabolic Syndrome | 1,500 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05872269) |
| August 25, 2022 | NCT05515367 | A Post Marketing Surveillance to Evaluate the Safety of Desidustat for the Treatment of Anemia in Subjects With Chronic Kidney Disease... | Zydus Lifesciences Limited | Phase 4 | Recruiting | Chronic Kidney Diseases, Anemia of Chronic Kidney Disease | 1,004 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05515367) |
| March 17, 2022 | NCT05283837 | A Study to Evaluate Safety, Efficacy, Pharmacokinetics, and Immunogenicity of Test Pertuzumab (ZRC-3277, Cadila Healthcare Ltd.,) | Zydus Lifesciences Limited | Phase 3 | Completed | Metastatic Breast Cancer | 268 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05283837) |
| January 25, 2022 | NCT05206201 | A Study Of Zy-19489 Administered Via Oral Route To Investigate The Safety, Tolerability And Pharmacokinetics In Healthy Adult Human Subjects | Zydus Lifesciences Limited | Phase 1 | Completed | Malaria | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05206201) |
| January 11, 2022 | NCT05186051 | A Clinical Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ZYIL1 in Subjects With Cryopyrin Associated... | Zydus Lifesciences Limited | Phase 2 | Completed | Cryopyrin Associated Periodic Syndrome | 3 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT05186051) |
| July 22, 2021 | NCT04972188 | A Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in... | Zydus Lifesciences Limited | Phase 1 | Completed | Healthy | 18 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04972188) |
| January 29, 2021 | NCT04731324 | Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of ZYIL1 Following Oral Administration in... | Zydus Lifesciences Limited | Phase 1 | Completed | Healthy | 30 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04731324) |
| December 14, 2020 | NCT04667533 | Desidustat in the Treatment of Chemotherapy Induced Anemia | Zydus Lifesciences Limited | Phase 1 | Completed | Anemia of Chronic Kidney Disease, Chemotherapy Effect | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04667533) |
| July 21, 2020 | NCT04480138 | Pegylated Interferon - α2b With SARSCoV- 2 (COVID-19) | Zydus Lifesciences Limited | Phase 2 | Terminated | Covid19 | 7 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04480138) |
| July 9, 2020 | NCT04463602 | Desidustat in the Management of COVID-19 Patients | Zydus Lifesciences Limited | Phase 2 | Completed | COVID-19 | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04463602) |
| January 2, 2020 | NCT04215120 | Desidustat in the Treatment of Anemia in CKD on Dialysis Patients | Zydus Lifesciences Limited | Phase 3 | Completed | Chronic Kidney Disease Stage 5 on Dialysis | 392 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04215120) |
| July 9, 2019 | NCT04012957 | Desidustat in the Treatment of Anemia in CKD | Zydus Lifesciences Limited | Phase 3 | Completed | Chronic Kidney Disease Stage 3, Anemia, Chronic Kidney Disease Stage 4, Chronic Kidney Disease Stage 5 | 588 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT04012957) |
| December 3, 2015 | NCT02620592 | Clinical Study to Evaluate the Safety, Tolerability and Pharmacokinetics (PKs) of ZYDPLA1 Following Oral Administration in Healthy... | Zydus Lifesciences Limited | Phase 1 | Completed | Diabetes Mellitus | 84 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02620592) |
| December 9, 2013 | NCT02005666 | To Compare the Efficacy and Safety of Clindamycin Phosphate 1.2% / Benzoyl Peroxide 5% Gel of CHL Versus DUAC® Gel | Zydus Lifesciences Limited | Phase 3 | Completed | Acne Vulgaris | 850 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT02005666) |
| October 31, 2013 | NCT01972893 | A Clinical Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of ZYD1, Following Subcutaneous Administration in Healthy... | Zydus Lifesciences Limited | Phase 1 | Completed | Type 2 Diabetes Mellitus | 56 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01972893) |
| March 2, 2012 | NCT01543269 | A Clinical Study to Evaluate the Safety,Tolerability and PK of ZYT1, Following Oral Administration in Healthy Volunteers | Zydus Lifesciences Limited | Phase 1 | Terminated | Obesity, Lipid Disorders | 24 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01543269) |
| February 27, 2012 | NCT01539616 | A Clinical Trial to Evaluate the Safety and Efficacy of ZYH7 Compared to Fenofibrate in Patients With Dyslipidemia | Zydus Lifesciences Limited | Phase 2 | Completed | Hypertriglyceridemia, Dyslipidemia | 109 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01539616) |
| November 17, 2011 | NCT01472809 | A Clinical Study to Evaluate Safety, Tolerability and Pharmacokinetics of Oral ZYGK1 in Healthy Volunteers | Zydus Lifesciences Limited | Phase 1 | Suspended | Diabetes | 96 | [clinicaltrials.gov](https://clinicaltrials.gov/study/NCT01472809) |

## By phase

| Phase | Trials |
| --- | --- |
| Phase 1 | 9 |
| Phase 2 | 6 |
| Phase 3 | 4 |
| Phase 4 | 2 |

## By status

| Status | Trials |
| --- | --- |
| Completed | 15 |
| Unknown | 2 |
| Terminated | 2 |
| Suspended | 1 |
| Recruiting | 1 |

## Conditions

| Condition group | Trials |
| --- | --- |
| COVID-19 | 3 |
| Dyslipidemias | 2 |
| Diabetes Mellitus, Type 2 | 2 |
| Diabetes Mellitus | 2 |
| Obesity | 2 |
| Renal Insufficiency, Chronic | 2 |
| Acne Vulgaris | 1 |
| Hypertriglyceridemia | 1 |
| Asymptomatic Diseases | 1 |
| Malaria, Falciparum | 1 |
| Amyotrophic Lateral Sclerosis | 1 |
| Colitis, Ulcerative | 1 |
| Malaria | 1 |
| Cryopyrin-Associated Periodic Syndromes | 1 |
| Non-alcoholic Fatty Liver Disease | 1 |
| Metabolic Syndrome | 1 |
| Anemia | 1 |
| Breast Neoplasms | 1 |
| Lipid Metabolism Disorders | 1 |

## Where the register publishes

- [ClinicalTrials.gov](https://clinicaltrials.gov/)
- [ClinicalTrials.gov API](https://clinicaltrials.gov/data-api/api)

Source: [ClinicalTrials.gov API v2 (U.S. National Library of Medicine)](https://clinicaltrials.gov/data-api/api). U.S. government data; ClinicalTrials.gov terms of use. Studies are as their sponsors registered them on ClinicalTrials.gov, read through its API. Recruiting means the record's overall status is recruiting or not yet recruiting. Condition groups are the MeSH terms ClinicalTrials.gov assigns; a condition page also counts the narrower terms that name it, as the register's own search does (triple negative breast neoplasms are breast neoplasms). Sites are shown as organizations only; no investigator or contact is read or shown.

Free to quote with credit and a link. Copying in bulk needs a [data licence](https://specstream.ai/data/licence).

## Business lists in the United States

- [B2B mining companies in the United States](https://specstream.ai/data/businesses/b2b-mining-companies/united-states)
- [Moving companies in the United States](https://specstream.ai/data/businesses/moving-companies/united-states)
- [Cambodian restaurants in the United States](https://specstream.ai/data/businesses/cambodian-restaurants/united-states)
- [Podiatrists in the United States](https://specstream.ai/data/businesses/podiatrists/united-states)
- [Dental clinics in the United States](https://specstream.ai/data/businesses/dental-clinics/united-states)
- [Seafood wholesalers in the United States](https://specstream.ai/data/businesses/seafood-wholesalers/united-states)
